Document:

Exhibit 10.2

 

 

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.

 

WARRANT

 

APPLIED DNA SCIENCES, INC.

	 	 
	Warrant No.:__	Issue Date: June 3, 2014

 

Applied DNA Sciences, Inc., a Delaware corporation (the “Company”), hereby certifies that ________________, for value received, (the “Warrant Holder,” which term includes its successors and registered assigns) is entitled, subject to the terms set forth below, to purchase an aggregate of ________ shares of common stock, par value $0.001 per share, of the Company (the “Common Stock”) at an exercise price of $0.13744 per share (the “Exercise Price”). The shares of Common Stock purchasable upon exercise of this Warrant, as adjusted from time to time pursuant to the provisions of this Warrant, are sometimes hereinafter referred to as the “Warrant Shares”.

 

NOW, THEREFORE, in consideration of the premises and the mutual covenants contained herein, the Company and the Warrant Holder hereby agree as follows:

 

1.   Exercise of Warrant. This Warrant may be exercised in whole or in part during the one-year period commencing on June 3, 2014 and expiring at 5:00 p.m., New York City time, on June 2, 2015 (the “Exercise Term”), or if such day is a day on which banking institutions in the State of New York are authorized by law to close, then on the next succeeding day which shall not be such a day, by presentation and surrender of this Warrant evidencing the Warrant to be exercised to the Company at its principal office or at the office of its stock transfer agent, if any, with the Exercise Form annexed hereto duly executed, and payment of the Exercise Price. If any Warrant should be exercised in part only, the Company shall, upon surrender of this Warrant for cancellation and presentment of the Exercise Form, execute and deliver a new Warrant or Warrants, as the case may be, evidencing the rights of the Warrant Holder thereof to purchase the balance of the shares purchasable thereunder. Upon receipt by the Company of this Warrant at its office, or by the stock transfer agent of the Company at its office, in proper form for exercise together with the payment of the Exercise Price, the Warrant Holder shall be deemed to be the holder of record of the Warrant Shares, notwithstanding that the stock transfer books of the Company shall then be closed or that certificates representing such Warrant Shares shall not then be actually delivered to the Warrant Holder. Certificates for the Warrant Shares shall be delivered to the Warrant Holder within a reasonable time following the exercise of this Warrant in accordance with the foregoing.

 

    	- 1 -

    	 

    
 

 

        2.   Reservation and Listing of Shares. The Company hereby agrees that at all times there shall be reserved for issuance and delivery upon exercise of this Warrant, such number of shares of its Common Stock as shall be required for issuance and delivery upon exercise of this Warrant. As long as this Warrant is outstanding, the Company shall use its best efforts to cause all shares of Common Stock issuable upon the exercise of this Warrant to be quoted on The Over The Counter Bulletin Board or the Over The Counter Market Group (“OTCQB”) or listed on NASDAQ or a national securities exchange, if such shares of Common Stock, as a class, are theretofore so quoted or listed.

 

        3.   Fractional Shares. No fractional shares or scrip representing fractional shares shall be issued upon the exercise of this Warrant. Any fraction of a share called for upon any exercise hereof shall be canceled. The Warrant Holder, by his acceptance hereof, expressly waives any right to receive any fractional share of stock or fractional Warrant upon exercise of this Warrant.

 

        4.   Exchange, Transfer, Assignment or Loss of Warrant. This Warrant is exchangeable, without expense, at the option of the Warrant Holder, upon presentation and surrender of this Warrant evidencing such Warrants to the Company at its office or at the office of its stock transfer agent, if any, for other Warrants of different denominations entitling the Warrant Holder thereof to purchase in the aggregate the same number of shares of Common Stock as are purchasable thereunder at the same respective Exercise Price. Subject to Section 8 hereof, upon surrender of this Warrant to the Company at its principal office or at the office of its stock transfer agent, if any, with a duly executed assignment form and funds sufficient to pay the applicable transfer tax, if any, the Company shall, without charge, execute and deliver new Warrant(s) in the name of the assignee named in such instrument of assignment and the original Warrant shall promptly be canceled. This Warrant may be divided or combined with other Warrants which carry the same rights upon presentation of this Warrant at the office of the Company or at the office of its stock transfer agent, if any, together with a written notice signed by the Warrant Holder hereof specifying the names and denominations in which new Warrants are to be issued. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation of this Warrant, and, in the case of loss, theft or destruction, of reasonably satisfactory indemnification, and upon surrender and cancellation of this Warrant, if mutilated, the Company will execute and deliver new Warrants of like tenor and date.

 

        5.   Rights of the Warrant Holder. The Warrant Holder shall not, by virtue hereof, be entitled to any rights of a shareholder of the Company until exercise of any Warrants.

 

        6.   Adjustments of Purchase Price and Number of Shares.

 

       (a)   Subdivision and Combination. If the Company shall at any time subdivide or combine the outstanding shares of Common Stock by way of stock split, reverse stock split or the like, the Exercise Price shall forthwith be proportionately increased or decreased.

 

    	- 2 -

    	 

    
 

 

       (b)   Adjustment in Number of Shares. Upon each adjustment of the Exercise Price pursuant to the provisions of paragraph 6(a), the number of shares of Common Stock issuable upon the exercise of this Warrant shall be adjusted to the nearest full share of Common Stock by multiplying a number equal to the Exercise Price in effect immediately prior to such adjustment by the number of shares of Common Stock issuable upon exercise of this Warrant immediately prior to such adjustment and dividing the product so obtained by the adjusted Exercise Price.

 

       (c)   Reclassification, Consolidation, Merger, etc. In case of any reclassification or change of the outstanding shares of Common Stock (other than a change in par value to no par value, or from no par value to par value, or as a result of a subdivision or combination), or in the case of any consolidation of the Company with, or merger of the Company into, another corporation (other than a consolidation or merger in which the Company is the surviving corporation and which does not result in any reclassification or change of the outstanding shares of Common Stock, except a change as a result of a subdivision or combination of such shares or a change in par value, as aforesaid), or in the case of a sale or conveyance to another corporation of all or a substantial part of the property of the Company, the Warrant Holder shall thereafter have the right to purchase the kind and number of shares of stock and other securities and property receivable upon such reclassification, change, consolidation, merger, sale or conveyance as if the Warrant Holder were the owner of the shares of Common Stock underlying this Warrant immediately prior to any such events at a price equal to the product of (x) the number of shares issuable upon exercise of this Warrant and (y) the Exercise Price in effect immediately prior to the record date for such reclassification, change, consolidation, merger, sale or conveyance as if such Warrant Holder had exercised this Warrant.

 

(d)   Dividends and Other Distributions with Respect to Outstanding Securities. In the event that the Company shall at any time prior to the exercise of all Warrants declare a dividend (other than a dividend consisting solely of shares of Common Stock or a cash dividend or distribution payable out of current or retained earnings) or otherwise distribute to the holders of its Common Stock any monies, assets, property, rights, evidences of indebtedness, securities (other than shares of Common Stock), whether issued by the Company or by another person or entity, or any other thing of value, the Warrant Holder of the unexercised Warrants shall thereafter be entitled, in addition to the shares of Common Stock or other securities receivable upon the exercise thereof, to receive, upon the exercise of such Warrants, the same monies, property, assets, rights, evidences of indebtedness, securities or any other thing of value that they would have been entitled to receive at the time of such dividend or distribution. At the time of any such dividend or distribution, the Company shall make appropriate reserves to ensure the timely performance of the provisions of this Subsection 6(d).

 

(e)   Warrant After Adjustment. Irrespective of any change pursuant to this Section 6 in the Exercise Price or in the number, kind or class of shares or other securities or other property obtainable upon exercise of this Warrant, this Warrant may continue to express as the Exercise Price and as the number of shares obtainable upon exercise, the same price and number of shares as are stated herein.

 

    	- 3 -

    	 

    
 

 

(f)   Statement of Calculation. Whenever the Exercise Price shall be adjusted pursuant to the provisions of this Section 6, the Company shall forthwith file at its principal office, a statement signed by an executive officer of the Company specifying the adjusted Exercise Price determined as above provided in such section. Such statement shall show in reasonable detail the method of calculation of such adjustment and the facts requiring the adjustment and upon which the calculation is based. The Company shall forthwith cause a notice setting forth the adjusted Exercise Price to be sent by certified mail, return receipt requested, postage prepaid, to the Warrant Holder.

 

7.   Definition of “Common Stock”. For the purpose of this Warrant, the term “Common Stock” shall mean, in addition to the class of stock designated as the Common Stock, $.001 par value, of the Company on the date hereof, any class of stock resulting from successive changes or reclassifications of the Common Stock consisting solely of changes in par value, or from par value to no par value, or from no par value to par value. If at any time, as a result of an adjustment made pursuant to one or more of the provisions of Section 6 hereof, the shares of stock or other securities or property obtainable upon exercise of this Warrant shall include securities of the Company other than shares of Common Stock or securities of another corporation, then thereafter the amount of such other securities so obtainable shall be subject to adjustment from time to time in a manner and upon terms as nearly equivalent as practicable to the provisions with respect to Common Stock contained in Section 6 hereof and all other provisions of this Warrant with respect to Common Stock shall apply on like terms to any such other shares or other securities.

 

8.   Restrictions on Offer and Sale. The Warrant Holder acknowledges that the shares of Common Stock acquired upon the exercise of this Warrant, if not registered, will have restrictions upon resale imposed by state and federal securities laws and shall bear a restrictive legend in substantially the following form:

 

NEITHER THIS SECURITY NOR THE SECURITIES FOR WHICH THIS SECURITY IS EXERCISABLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES LAWS.

 

THE SALE, ASSIGNMENT, CONVEYANCE, PLEDGE, HYPOTHECATION OR TRANSFER OF THE SECURITIES REPRESENTED BY THIS WARRANT IS PROHIBITED EXCEPT (1) PURSUANT TO REGISTRATION UNDER THE ACT OR (2) PURSUANT TO AN AVAILABLE EXEMPTION FROM REGISTRATION UNDER THE ACT, AND ANY CERTIFICATE REPRESENTING WARRANT SHARES SHALL BEAR A LEGEND TO SUCH EFFECT.

 

    	- 4 -

    	 

    
 

 

9.   Notices to Warrant Holders. Nothing contained in this Warrant shall be construed as conferring upon the Warrant Holder the right to vote or to consent or to receive notice as a shareholder in respect of any meetings of shareholders for the election of directors or any other matter, or as having any rights whatsoever as a shareholder of the Company. If, however, at any time prior to the expiration of this Warrant and its exercise, any of the following events shall occur:

 

   (a)   The Company shall take a record of the holders of its shares of Common Stock for the purpose of entitling them to receive a dividend or distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise than out of current or retained earnings, as indicated by the accounting treatment of such dividend or distribution on the books of the Company; or

 

   (b)           The Company shall offer to all the holders of its Common Stock any additional shares of capital stock of the Company or securities convertible into or exchangeable for shares of capital stock of the Company, or any warrant, right or option to subscribe therefor; or

 

   (c)   A dissolution, liquidation or winding up of the Company (other than in connection with a consolidation or merger) or a sale of all or substantially all of its property, assets and business shall be proposed; or

 

   (d)           There shall be any capital reorganization or reclassification of the capital stock of the Company, or consolidation or merger of the Company with another entity; then, in anyone or more of said events, the Company shall give written notice of such event at least fifteen (15) days prior to the date fixed as a record date or the date of closing the transfer books for the determination of the shareholders entitled to such dividend, distribution, convertible or exchangeable securities or subscription rights, warrants or options, or entitled to vote on such proposed dissolution, liquidation, winding up or sale. Such notice shall specify such record date or the date of closing the transfer books, as the case may be. Failure to give such notice or any defect therein shall not affect the validity of any action taken in connection with the declaration or payment of any such dividend or distribution, or the issuance of any convertible or exchangeable securities or subscription rights, warrants or options, or any proposed dissolution, liquidation, winding up or sale.

 

10.          Notices.

 

   (a)   All communications under this Warrant shall be in writing and shall be mailed by certified mail, postage prepaid, return receipt requested, or telecopied with confirmation of receipt or delivered by hand or by overnight delivery service:

	 	 	 	 
	 	

If to the Company at:

	 	

Applied DNA Sciences, Inc.

	 	 	 	

Attn: Karol Kain Gray, Chief Financial Officer

	 	 	 	

50 Health Sciences Drive

	 	 	 	

Stony Brook, New York 11790

 

    	- 5 -

    	 

    
 

 

If to the Warrant Holder, to the address of such Warrant Holder as it appears in the stock or warrant ledger of the Company.

 

   (b)   Any notice so addressed, when mailed by registered or certified mail shall be deemed to be given three days after so mailed, when telecopied shall be deemed to be given when transmitted, or when delivered by hand or overnight shall be deemed to be given when hand delivered or on the day following deposit with the overnight delivery service.

 

11.          Successors. All the covenants and provisions of this Warrant by or for the benefit of the Warrant Holder shall inure to the benefit of his successors and assigns hereunder.

 

12.          Termination. This Warrant (and the right to purchase Warrant Shares upon exercise hereof) will terminate on June 2, 2015.

 

13.          Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Warrant shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New York. The Company hereby irrevocably submits to the exclusive jurisdiction of the state and federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. In the event that any provision of this Warrant is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform to such statute or rule of law. Any such provision which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of this Warrant.

 

14.          Entire Agreement, Amendment, Waiver. This Warrant and all attachments hereto and all incorporation by references set forth herein, set forth the entire agreement and understanding between the parties as to the subject matter hereof and merges and supersedes all prior discussions, agreements and understandings of any and every nature among them. This Warrant may be amended, the Company may take any action herein prohibited or omit to take any action herein required to be performed by it, and any breach of any covenant, agreement, warranty or representation may be waived, only if the Company has obtained the written consent or waiver of the Warrant Holder. No course of dealing between or among any persons having any interest in this Warrant will be deemed effective to modify, amend or discharge any part of this Warrant or any rights or obligations of any person under or by reason of this Warrant.

 

    	- 6 -

    	 

    
 

 

THIS SPACE INTENTIONALLY LEFT BLANK; SIGNATURE PAGE FOLLOWS

 

    	- 7 -

    	 

    
 

 

IN WITNESS WHEREOF, the undersigned has executed this Warrant as of this 3rd  day of June, 2014.

 

	 	 	 
	 	APPLIED DNA SCIENCES, INC.	 
	 	 	 	 
	 	 	 	 
	 	
By: 

	 	 
	 	Name: Karol Kain Gray	 
	 	

Title: Chief Financial Officer

	 

 

    	- 8 -

    	 

    
 

 

APPLIED DNA SCIENCES, INC. 

 

WARRANT ASSIGNMENT FORM

 

(To be signed only upon assignment of Warrant)

 

 

FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto

	 
	 
	 

(Name and address of assignee must be printed or typewritten)

 

the rights of the undersigned with respect to the Warrant surrendered herewith to the extent of ( ___________________ ) shares of Common Stock, $.001 par value per share, of Applied DNA Sciences, Inc. (the “Company”), hereby irrevocably constituting and appointing _________________ , attorney to make such transfer on the books of the Company, with full power of substitution in the premises.

  

	 	 	 
	Dated:                                                        	 	 
	 	 	

Signature of Registered Holder

	 	 	 
	

Signature(s) Guaranteed:

	 	 
	 	 	

Signature of Registered Holder, if more than one

	 	 	 
	 	 	 
	 	 	

Name of Registered Holder

	 	 	 
	 	 	 
	 	 	

Name of Registered Holder, if more than one

 

	
  

	
Note:

	
The above signature(s) must correspond with the name(s) as it (they) appear(s) upon the Warrant in every particular, without alteration or enlargement or any change whatever.

 

    	- 9 -

    	 

    
 

 

APPLIED DNA SCIENCES, INC.

 

WARRANT EXERCISE FORM

 

(To be executed upon exercise of  Warrant)

 

The undersigned, the record holder of this Warrant, hereby irrevocably elects to exercise the right, represented by this Warrant, to purchase               of the Warrant Shares.

The undersigned requests that a certificate for the Warrant Shares being purchased be registered in the name of               and that such certificate be delivered to                .

 

	 	 	 
	

Dated:___________

	 	 
	 	 	

(Signature)

	 	 	 
	 	 	 
	 	 	

(Printed Name)

	 	 	 

 

    	- 10 -Ex_10.1_(8-KA_June 4 2014_Alfinsa_purchase_K)

EXHIBIT 10.1

Execution Copy
AMENDMENT NO. 1 TO  
PURCHASE AGREEMENT
This AMENDMENT NO. 1, dated as of June 4, 2014 (this “Amendment”), to the Purchase Agreement, dated as of February 26, 2014 (the “Purchase Agreement”), is made by and among the parties to the Purchase Agreement, being Afinsa Bienes Tangibles, S.A. En Liquidación, a Spanish corporation (“Afinsa”), Auctentia, S.L., a Spanish corporation (“Auctentia” and together with Afinsa, the “Selling Stockholders”), Spectrum Group International, Inc., a Delaware corporation (“SGI”), and A-Mark Precious Metals, Inc., a Delaware corporation (“A-Mark”).  Capitalized terms used in this Amendment without definition have the meanings assigned to them in the Purchase Agreement.
R E C I T A L S
WHEREAS, the Spinoff was effected on March 14, 2014; and
WHEREAS, the Purchase Agreement provides that the purchase and sale of the Afinsa A-Mark Shares and the Auctentia A-Mark Shares and the purchase and sale of the Afinsa SGI Shares and the Auctentia SGI Shares shall occur together at the Second Closing; and
WHEREAS, the parties desire that the purchase and sale of the Afinsa A-Mark Shares and the Auctentia A-Mark Shares shall occur on the date hereof, and that the purchase and sale of the Afinsa SGI Shares and the Auctentia SGI Shares occur at such time as originally provided in Section 2.3(b) of the Purchase Agreement;
NOW, THEREFORE, in consideration of the mutual representations, warranties, covenants and agreements herein contained, the parties hereto agree as follows:
1.The introductory clause of Section 2.1(b) of the Purchase Agreement is hereby amended and restated as follows:
“(b)    At closings to occur on or prior to July 1, 2014, as provided in
Section 2.3(b) (collectively the “Second Closing”):”
2.    Section 2.3(b) of the Purchase Agreement is hereby amended and restated as follows:
“(b)    The first part of the Second Closing (the “First Part”) is being held concurrently with the execution of Amendment No. 1 to the Agreement at the offices of Kramer Levin Naftalis & Frankel LLP, 1177 Avenue of the Americas, New York, New York. At the First Part:
(i)    Afinsa is delivering, or causing to be delivered, to A-Mark (1) all certificates for, and evidence of ownership of, the shares of A-Mark Common 

Stock to be sold by Afinsa at the Second Closing held in certificate form, duly endorsed for transfer or accompanied by a duly executed stock power, and (2) to the extent any such shares are not held in certificate form, by credit to an account at The Depository Trust Company heretofore designated by A-Mark;
(ii)    Auctentia is delivering, or causing to be delivered, to A-Mark (1) all certificates for, and evidence of ownership of, the shares of A-Mark Common Stock being sold by Auctentia at the Second Closing held in certificate form, duly endorsed for transfer or accompanied by a duly executed stock power, and (2) to the extent any such shares are not held in certificate form, by credit to an account at The Depository Trust Company heretofore designated by A-Mark; and
(iii)    A-Mark is paying the A-Mark Portion of the Second Payment plus interest as provided in Section 2.2, to the Selling Stockholders, in accordance with Section 2.2.
The second part of the Second Closing (the “Second Part”) shall take place at 9:00 a.m. Eastern time on the fourth (4th) Business Day following notification thereof by SGI to the Selling Stockholders, but in no event later than July 1, 2014, at the offices of Kramer Levin Naftalis & Frankel LLP, 1177 Avenue of the Americas, New York, New York. At the Second Part:
(iv)    Afinsa shall deliver, or cause to be delivered, to SGI (1) all certificates for, and evidence of ownership of, the shares of SGI Common Stock to be sold by Afinsa at the Second Closing held in certificate form, duly endorsed for transfer or accompanied by a duly executed stock power, and (2) to the extent any such shares are not held in certificate form, by credit to an account at The Depository Trust Company heretofore designated by SGI;
(v)    Auctentia shall deliver, or cause to be delivered, to SGI (1) all certificates for, and evidence of ownership of, the shares of SGI Common Stock being sold by Auctentia at the Second Closing held in certificate form, duly endorsed for transfer or accompanied by a duly executed stock power, and (2) to the extent any such shares are not held in certificate form, by credit to an account at The Depository Trust Company heretofore designated by SGI; and
(vi)    SGI shall pay the SGI Portion of the Second Payment, plus interest as provided in Section 2.2, to the Selling Stockholders, in accordance with Section 2.2.”
3.    Section 5.2 of the Purchase Agreement is hereby amended and restated as follows:
“5.2    Resignation.  Afinsa shall cause Antonio Arenas to have tendered his resignation as a director of SGI on or prior to the date of the Second Part of the Second Closing.”

- 2 -

4.    For purposes of the First Part of the Second Closing, Article IV (“Conditions to the Second Closing”) of the Purchase Agreement shall be applied by eliminating references therein to SGI and the occurrence of the Spinoff.
5.    Article IV (“Conditions to the Second Closing”) and Article VI (“Termination”) of the Purchase Agreement shall be applied, from and after the occurrence of the First Part of the Second Closing, as follows:
(a)    By replacing all references to the “Second Closing” to “Part Two of the Second Closing.”
(b)    By eliminating all references therein to A-Mark and the occurrence of the Spinoff.
6.    The provisions of Article VII of the Purchase Agreement shall apply to this Amendment mutatis mutandis.
7.    Except as otherwise provided in this Amendment, the Purchase Agreement shall remain in full force and effect.
[Remainder of page intentionally left blank; 
signatures on next succeeding page.]

- 3 -

IN WITNESS WHEREOF, the parties have executed and delivered this Amendment on the date first above written.
AFINSA BIENES TANGIBLES. S.A. EN LIQUIDACION

By:    /s/  Javier Díaz-Galvez de la Cámara     
Name:    Javier Díaz-Galvez de la Cámara
Title:    Trustee

By:    /s/  Benito Agüera Martin  
Name:    Benito Agüera Martin
Title:    Trustee

By:    /s/  Carmen Salvador Calvo 
Name:    Carmen Salvador Calvo 
In representation of Tesoreria General del la 
Seguridad Social 
Title:  Trustee

AUCTETIA, S.L.

By:     /s/  Javier Díaz-Galvez de la Cámara 
Name:    Javier Díaz-Glávez de la Cámara 
Title:    Joint Administrator

By:    /s/  Benito Agüera Martin  
Name:    Benito Agüera Marin 
Title:    Joint Administrator

[SIGNATURES CONTINUE ON FOLLOWING PAGE]

- 4 -

SPECTRUM GROUP INTERNATIONAL, INC.

By:    /s/  Carol Meltzer     
Name:    Carol Meltzer
Title:    Executive Vice President, General 
    Counsel and Corporate Secretary

A-MARK PRECIOUS METALS, INC.

By:    /s/  Carol Meltzer 
Name:    Carol Meltzer
Title:    Executive Vice President, General 
    Counsel and Corporate Secretary

[Signature Page to Amendment No. 1 to Purchase Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00231-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00231-of-00352.parquet"}]]